Skip to content

Brimonidine Impurity 17

Brimonidine Impurity 17

Product Description
CAT No.
ALN-B026046
CAS No.
NA
Mol. F.
C15H12BrN5O3
Mol. Wt.
390.2
Stock
Please Inquire
RFQ
Chemical Name : (Z)-1-(5-Bromoquinoxalin-6-yl)-3-hydroxy-8,9-dihydro-1H-imidazo[2,1-c][1,2,4]oxadiazocin-6(5H)-one
Smiles : O=C1N2C(N(C3=CC=C4N=CC=NC4=C3Br)O/C(O)=C\C1)=NCC2
Inchi : InChI=1S/C10H6N2O5/c1-5(13)12(11-16)7-4-2-3-6-8(7)10(15)17-9(6)14/h2-4H,1H3

Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma

B.Chianga1Y.C.Kimb1A.C.Dotyc12H.E.GrossniklausdS.P.SchwendemancM.R.PrausnitznJournal of Controlled Release Volume 228, 28 April 2016, Pages 48-57

Sustained release of brimonidine from a new composite drug delivery system for treatment of glaucoma

Jianguo Sun, Yuan Lei, Zhaoxing Dai∥, Xi Liu, Taomin Huang, Jihong Wu, Zhi Ping XOrcid, and Xinghuai Sun – ACS Appl. Mater. Interfaces 2017, 9, 9, 7990–7999

A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems

Jianguo Sun, Xiuwen Zhang & Taomin Huang – Chemistry Central Journal volume 11, Article number: 62 (2017)

Request For Quotation

Related Products